1.5 ml semaglutide / Cyanocobalamin Injection is now available for bulk order in 5-vial increments from our FDA-registered 503B outsourcing facility. Ready-to-use formulations — no additional prep needed. 📷 Available strengths: 1 / 0.5 Semaglutide 5mg/ml dosage chart: complete

With the emergence of GLP-1s, there is a divide between patient perception of the medication and how clinical science views it

Introduction: Obesity is a global epidemic affecting 2.5 billion people and is recognized as the fourth leading cause of global mortality

When appetite is reduced, it may be helpful to include protein at meals and snacks

Overall, the GLP-1 market is expected to experience annual growth exceeding 20% and will hit $133 billion worldwide by 2030, according to a MarketWatch report from February.

Glucagon-like peptide-1 (GLP-1) receptor agonists were touted as breakthrough drugsin 2023 and their popularity has soared since. More than 4 million items of tirzepatide and semaglutide were dispensed on the NHS in England in 2025/20261, while around2.5 million people each monthaccessed GLP-1s privately at the end of 2025, according to James Kingsland, chair of []

LY3437943, a Novel Triple Glucagon, GIP, and GLP-1 Receptor Agonist for Glycemic Control and Weight Loss: From Discovery to Clinical Proof of Concept, Coskun T